CollPlant Biotechnologies CLGN
NASDAQ CLGN
$3.88 +0.32 (+8.99%)
As of: Oct 20, 2026 · 3:59 PM EDT

CollPlant Biotechnologies (CLGN) Enterprise Value (2018 - 2026)

Updated

CollPlant Biotechnologies' Enterprise Value was $1.52 million in the quarter ended Jun 30, 2026, down 60.8% from $3.87 million a year earlier and down 79.9% from the prior quarter.

Analysis

CollPlant Biotechnologies (CLGN) Enterprise Value (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, CollPlant Biotechnologies' Enterprise Value was -$24.97 million through Jun 30, 2026; for the year ended Dec 31, 2025, it came in at $11.97 million, down 58.8% from the prior year.

  • Enterprise Value has now declined for four consecutive years, with a five-year compound annual growth rate of -30.0% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Enterprise Value was $29.08 million in the year ended Dec 31, 2024 (-32.5%), $43.08 million in the year ended Dec 31, 2023 (-32.4%), $63.73 million in the year ended Dec 31, 2022 (-60.9%) and $162.84 million in the year ended Dec 31, 2021 (+127.9%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Enterprise Value in data going back to the quarter ended Mar 31, 2018.
  • Compared with a year earlier, Enterprise Value has declined for seven straight quarters, with an average decline of 45.1% over the last eight quarters.
  • The best year-over-year quarter for Enterprise Value over five years was the quarter ended Dec 31, 2021 (growth of 128.2%); the worst was the quarter ended Jun 30, 2025 (a decline of 89.7%).
  • Per Business Quant data, CLGN's Enterprise Value in the three quarters before the quarter ended Jun 30, 2026 was $7.55 million (quarter ended Mar 30, 2026), $11.97 million (quarter ended Dec 31, 2025) and $21.98 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 CollPlant Biotechnologies 4.68 Mn -17.68 Mn -456,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.52 Mn
Mar 31, 2026 2.24 Mn
Dec 31, 2025 11.97 Mn
Sep 30, 2025 21.98 Mn
Jun 30, 2025 3.87 Mn
Mar 31, 2025 18.57 Mn
Dec 31, 2024 29.08 Mn
Sep 30, 2024 41.25 Mn
Jun 30, 2024 37.76 Mn
Mar 31, 2024 37.81 Mn
Dec 31, 2023 46.27 Mn
Sep 30, 2023 33.10 Mn
Jun 30, 2023 68.98 Mn
Mar 31, 2023 51.98 Mn
Dec 31, 2022 63.73 Mn
Sep 30, 2022 40.41 Mn
Jun 30, 2022 49.65 Mn
Mar 31, 2022 79.78 Mn
Dec 31, 2021 163.07 Mn
Sep 30, 2021 91.92 Mn
API Access

CollPlant Biotechnologies Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=CLGN&period=max&api_key=YOUR_API_KEY